Avadel Pharma (AVDL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov26

Jefferies Maintains Hold Rating on Avadel Pharmaceuticals

21:17

Nov19

Alkermes Increases Bid for Avadel Pharmaceuticals to $2.37 Billion

11:07

Alkermes Increases Bid for Avadel

11:01

Nov18

Citadel Group Discloses Stake and Short Position in Avadel Pharmaceuticals plc

15:03

Nov17

Janus Henderson Discloses Position and Short Interest in Avadel Pharmaceuticals

14:37

Geode Capital Discloses Its Stake in Avadel Pharmaceuticals

13:37

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 77.47 M, Net Income 20 K, EPS 0.0001

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 68.13 M, Net Income 9.665 M, EPS 0.0999

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 52.51 M, Net Income -4.92 M, EPS -0.0509

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More